ITGB5 and AGFG1 variants are associated with severity of airway responsiveness
Author
Himes, BlancaQiu, Weiliang
Klanderman, Barbara
Ziniti, John
Senter-Sylvia, Jody
Szefler, Stanley
Lemanske, Jr, Robert
Zeiger, Robert
Strunk, Robert
Martinez, Fernando
Boushey, Homer
Chinchilli, Vernon
Israel, Elliot
Mauger, David
Koppelman, Gerard
Nieuwenhuis, Maartje
Postma, Dirkje
Vonk, Judith
Rafaels, Nicholas
Hansel, Nadia
Barnes, Kathleen
Raby, Benjamin
Tantisira, Kelan
Weiss, Scott
Affiliation
Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USAPartners HealthCare Center for Personalized Genetic Medicine and Harvard Medical School, Boston, MA, USA
Children’s Hospital Informatics Program, Boston, MA, USA
National Jewish Health and University of Colorado Denver School of Medicine, Denver, CO, USA
University of Wisconsin, Clinical Science Center, Madison, WI, USA
Kaiser Permanente Southern California Region, San Diego, CA, USA
Washington University School of Medicine, St. Louis, MO, USA
Arizona Respiratory Center, University of Arizona, College of Medicine, Tucson, AZ, USA
Division of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, University of California at San Francisco, San Francisco, CA, USA
Department of Biostatistics, Penn State College of Medicine, Hershey, PA, USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
Department of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children’s Hospital, GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Department of Pulmonology and Tuberculosis, GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Department of Epidemiology, GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
Issue Date
2013
Metadata
Show full item recordPublisher
BioMed CentralCitation
Himes et al. BMC Medical Genetics 2013, 14:86 http://www.biomedcentral.com/1471-2350/14/86Journal
BMC Medical GeneticsRights
© 2013 Himes et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).Collection Information
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.Abstract
BACKGROUND:Airway hyperresponsiveness (AHR), a primary characteristic of asthma, involves increased airway smooth muscle contractility in response to certain exposures. We sought to determine whether common genetic variants were associated with AHR severity.METHODS:A genome-wide association study (GWAS) of AHR, quantified as the natural log of the dosage of methacholine causing a 20% drop in FEV1, was performed with 994 non-Hispanic white asthmatic subjects from three drug clinical trials: CAMP, CARE, and ACRN. Genotyping was performed on Affymetrix 6.0 arrays, and imputed data based on HapMap Phase 2, was used to measure the association of SNPs with AHR using a linear regression model. Replication of primary findings was attempted in 650 white subjects from DAG, and 3,354 white subjects from LHS. Evidence that the top SNPs were eQTL of their respective genes was sought using expression data available for 419 white CAMP subjects.RESULTS:The top primary GWAS associations were in rs848788 (P-value 7.2E-07) and rs6731443 (P-value 2.5E-06), located within the ITGB5 and AGFG1 genes, respectively. The AGFG1 result replicated at a nominally significant level in one independent population (LHS P-value 0.012), and the SNP had a nominally significant unadjusted P-value (0.0067) for being an eQTL of AGFG1.CONCLUSIONS:Based on current knowledge of ITGB5 and AGFG1, our results suggest that variants within these genes may be involved in modulating AHR. Future functional studies are required to confirm that our associations represent true biologically significant findings.EISSN
1471-2350Version
Final published versionAdditional Links
http://www.biomedcentral.com/1471-2350/14/86ae974a485f413a2113503eed53cd6c53
10.1186/1471-2350-14-86
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2013 Himes et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).

